Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment

MLA

Yee Soo Chae, et al. “Predictive Value of Pretreatment Risk Group and Baseline LDH Levels in MDS Patients Receiving Azacitidine Treatment.” Annals of Hematology, vol. 89, Mar. 2010, pp. 681–89. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8b844e6cb356485fa1c56f7475a7e7b8&authtype=sso&custid=ns315887.

APA

Yee Soo Chae, Sang Min Lee, Young Don Joo, Jong Gwang Kim, Moo Kon Song, Yeo Kyeoung Kim, Jae Hoo Park, Jong-Ho Won, Byung Woog Kang, Hyeong Joon Kim, Joon Ho Moon, Joo Seop Chung, Shi Nae Kim, Sang Kyun Sohn, Jin Ho Baek, & Deog Yeon Jo. (2010). Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment. Annals of Hematology, 89, 681–689.

Chicago

Yee Soo Chae, Sang Min Lee, Young Don Joo, Jong Gwang Kim, Moo Kon Song, Yeo Kyeoung Kim, Jae Hoo Park, et al. 2010. “Predictive Value of Pretreatment Risk Group and Baseline LDH Levels in MDS Patients Receiving Azacitidine Treatment.” Annals of Hematology 89 (March): 681–89. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8b844e6cb356485fa1c56f7475a7e7b8&authtype=sso&custid=ns315887.